GCG (340450.KQ)
GC Genome Corporation operates as a clinical genome analysis company in South Korea.
4,450.00+0.03%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-43.2%
The outlook
GCG currently reads as bearish based on below its 50- & 200-day averages, 6% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range6% of the way from its 52-week low to high
Market cap
$105.25B
52-wk high
9,520.00
52-wk low
4,100.00
50-day avg
5,199.00
200-day avg
6,919.80
Trailing P/E
—